A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population
Active, not recruitingOBSERVATIONAL
Enrollment
861
Participants
Timeline
Start Date
January 3, 2025
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2025
Conditions
Sleep Initiation and Maintenance DisordersPregnancy
Interventions
OTHER
No Intervention
This is a non-interventional study.
Trial Locations (1)
07110
Eisai Trial Site #1, Nutley
All Listed Sponsors
lead
Eisai Inc.
INDUSTRY
NCT06744673 - A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population | Biotech Hunter | Biotech Hunter